![]() |
5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV8–11 July 2003, Le Meridien Montparnasse, Paris, France |
INCRETIN HORMONE RESPONSE TO ORAL GLUCOSE IS PRESERVED IN LIPODYSTROPHIC HIV PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
O Andersen1, SB Haugaard1,2, JJ Holst3, J Iversen1, UB Andersen4, JO Nielsen1 and S Madsbad2
1of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark; 2Department of Endocrinology and Internal Medicine, Hvidovre University Hospital, Copenhagen, Denmark; 3Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark; and 4Department of Clinical Physiology, Hvidovre University Hospital, Denmark
OBJECTIVES: Patients with HIV-associated lipodystrophy syndrome (LIPO) exhibit insulin resistance and, more often, impaired glucose tolerance (IGT) compared with HIV patients without lipodystrophy (NONLIPO). The incretin hormones glucagon-like-peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are major regulators of glucose tolerance by stimulating insulin secretion. It is not known whether reduced incretin responses contribute to IGT amongst LIPO.
METHODS: Six LIPO with normal glucose tolerance (NGT), eight LIPO with IGT and 12 NONLIPO with NGT (all Caucasian males) underwent a 180 min oral 75 g glucose tolerance test, including frequent measurements of plasma glucose, insulin, C-peptide, GLP-1 and GIP.
RESULTS: IGT LIPO compared with NGT NONLIPO exhibited increased area under the curve (AUC) of glucose (+24%, P=0.0002), AUC-insulin (+61%, P=0.01), AUC-C-peptide (+40%, P=0.03), AUC-GLP-1 (+37%, P=0.15) and incremental AUC-GLP-1 (+85%, P=0.04), respectively, whereas AUC-GIP did not differ between these groups (P=0.70). Between NGT LIPO and NGT NONLIPO values of GLP-1 and GIP were not significantly different.
CONCLUSIONS: GLP-1 secretion was not impaired in IGT LIPO. On the contrary, in IGT LIPO the incremental GLP-1 response was increased compared with NGT NONLIPO, perhaps reflecting a compensatory response rather than explaining the IGT.
Presenting author: O Andersen
2003-07-08
41
Copyright © 2003 - International Medical Press Ltd.. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Medical Editor, International Medical Press, 36 St Mary-at-Hill, London EC3R 8DU, United Kingdom.